Financials
- Market Capitalization 596.99 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.1
Relación precio/flujo de caja
5.1
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2789 | MDXG MiMedx Group, Inc - Common Stock | 4.13 USD | +1.23% | 0.00% | +13.15% | -34.03% | 615.15 M USD | ||
| 2794 | NGNE Neurogene Inc. - Common Stock | 37.15 USD | -3.05% | +13.47% | +26.62% | +26.27% | 587.04 M USD | ||
| 2820 | ALT Altimmune, Inc. - Common Stock | 2.98 USD | -0.33% | -1.00% | +13.74% | -30.54% | 579.53 M USD | ||
| 2824 | DRUG Bright Minds Biosciences Inc. - common stock | 75.40 USD | -0.70% | +15.10% | +21.91% | +190.45% | 575.74 M USD |